サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1429600

医薬品開発製造受託機関（CDMO）の世界市場レポート 2024

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医薬品開発製造受託機関（CDMO）の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

医薬品開発製造受託機関（CDMO）の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には18.8%の年間複合成長率（CAGR）で2,980億3,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、政府支援の拡大、ヘルスケアアクセスの改善、投資の増加、バイオ医薬品開発の増加などの要因によって促進されると予想されます。この時期の注目すべき動向としては、持続可能性の重視の高まり、人工知能とデジタル化の統合、レジリエンスに重点を置いた革新的な製品のイントロダクション、投資の増加、市場関係者間の戦略的パートナーシップやコラボレーションなどが挙げられます。

医薬品開発製造受託機関（CDMO）市場の拡大は、世界の医薬品需要の増加によって促進されています。病気の有病率の高まりと長寿への要望により、医薬品の需要が急増しています。これにより、製薬会社は新薬の創出を促進するために既存薬の生産を強化し、研究開発（R&D）投資を増強するようになりました。これらの需要に応えて、製薬会社は運営コストを削減するための戦略的アプローチとして製造受託機関（CMO）との協力に取り組んでおり、それによって医薬品の受託開発および製造市場に対する需要の高まりを促進しています。バイオ医薬品会社のAlkermes PLCによると、医薬品の受託製造は、コスト削減の必要性から、大企業から小規模の専門製薬会社に至るまで、さまざまな規模の企業にとって戦略的な選択肢になりつつあります。

医薬品開発製造受託機関（CDMO）市場で予想される成長は、特許失効のエスカレート現象によってさらに促進されます。特許の有効期限は、発明者または特許所有者に一定期間付与された法的に保護された独占的権利の終了を意味し、発明の製造、販売、または使用が許可されます。医薬品開発製造受託は、ジェネリック医薬品の迅速な開発と生産を促進する上で重要な役割を果たし、特許満了後の市場参入を可能にします。たとえば、米国を拠点とするWebサービスプラットフォームであるDrugPatentWatchは、2023年に合計 37の医薬品が特許期限切れに直面し、ジェネリック市場参入への道が開かれると報告しています。したがって、特許有効期限の延長は、医薬品開発製造受託機関（CDMO）市場にとって重要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の医薬品開発製造受託機関（CDMO）市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 受託製造サービス
  • 受託調査サービス
  • 世界の医薬品開発製造受託機関（CDMO）市場、調査フェーズ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 前臨床
  • フェーズI
  • フェーズ II
  • フェーズⅢ
  • フェーズ IV
  • 世界の医薬品開発製造受託機関（CDMO）市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 大手製薬会社
  • ジェネリック医薬品会社
  • 中小規模の製薬会社

第7章 地域および国の分析

  • 世界の医薬品開発製造受託機関（CDMO）市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の医薬品開発製造受託機関（CDMO）市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医薬品開発製造受託機関（CDMO）市場の競合情勢
  • 医薬品開発製造受託機関（CDMO）市場の企業プロファイル
    • Lonza Group
    • Catalent Inc
    • WuXi AppTec Inc.
    • Pfizer Inc
    • Recipharm AB

第31章 その他の大手および革新的な企業

  • Almac Group
  • Aenova Group
  • Baxter International Inc
  • SGS Life Science Services SA
  • Jubilant Pharmova Ltd
  • Dishman Pharmaceuticals
  • Kemwell Pvt. Ltd.
  • Nipro Corp.
  • CMIC Group
  • Sawai Pharmaceutical Co., Ltd
  • IDT Australia Limited
  • Aurigene Pharmaceutical Services Limited
  • Vetter Pharma International GMBH
  • Consort Medical PLC
  • Siegfried Holding AG

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14571

Pharmaceutical Contract Development and Manufacturing (CDMO) involves businesses that provide services for drug research and manufacturing in the pharmaceutical sector. Pharmaceutical companies can choose to outsource drug development and production by partnering with CDMOs. Full-service CDMOs are capable of managing every stage of the process, accommodating clients who wish to outsource specific steps in their workflow. The services provided are tailored to the specific requirements of each client.

Pharmaceutical Contract Development and Manufacturing Organizations (CMO) primarily offer contract manufacturing services and contract research services. Contract manufacturing services involve outsourcing manufacturing processes or goods production to a third-party company, commonly known as a contract manufacturer. The research phases encompass preclinical, phase I, phase II, phase III, and phase IV. End-use sectors for CDMOs include large pharmaceutical companies, generic pharmaceutical companies, and small to medium-sized pharmaceutical companies.

The pharmaceutical contract development and manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing market statistics, including pharmaceutical contract development and manufacturing industry global market size, regional shares, competitors' pharmaceutical contract development and manufacturing market share, detailed pharmaceutical contract development and manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing industry. This pharmaceutical contract development and manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical contract development & manufacturing organization (CMO) market size has grown strongly in recent years. It will grow from $139.92 billion in 2023 to $149.65 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The expansion observed in the historical period can be ascribed to robust economic growth in emerging markets, a surge in healthcare expenditure, an escalation in pharmaceutical research and development (R&D) spending, and a growing inclination towards outsourcing.

The pharmaceutical contract development & manufacturing organization (CMO) market size is expected to see rapid growth in the next few years. It will grow to $298.03 billion in 2028 at a compound annual growth rate (CAGR) of 18.8%. The anticipated growth in the forecast period is expected to be driven by factors such as growing government support, improved healthcare access, increased investments, and a rise in biopharmaceutical development. Notable trends during this period include a heightened emphasis on sustainability, the integration of artificial intelligence and digitalization, the introduction of innovative products with a resilience focus, as well as increased investments and strategic partnerships and collaborations among market players.

The expansion of the pharmaceutical contract development and manufacturing market is fueled by the global increase in demand for medicines. The heightened prevalence of diseases, coupled with the desire for longer lifespans, has led to a surge in the demand for medications. This, in turn, has prompted pharmaceutical companies to intensify the production of existing drugs and augment their research and development (R&D) investments to facilitate the creation of new drugs. In response to these demands, pharmaceutical companies are engaging in collaborations with contract manufacturing organizations (CMOs) as a strategic approach to reducing operational costs, thereby fostering an elevated demand for the pharmaceutical contract development and manufacturing market. According to Alkermes PLC, a biopharmaceutical company, pharmaceutical contract manufacturing is becoming a strategic choice for companies of varying sizes, from large enterprises to smaller specialty pharma entities, driven by the imperative to cut costs.

The anticipated growth in the pharmaceutical contract development and manufacturing market is further propelled by the escalating phenomenon of patent expiration. Patent expiration signifies the conclusion of the legally protected exclusive rights granted to an inventor or patent holder for a specified duration, allowing them to make, sell, or use the invention. Pharmaceutical contract development and manufacturing play a crucial role in facilitating the rapid development and production of generic drugs, enabling their entry into the market upon the expiration of patents. For example, in 2023, DrugPatentWatch, a US-based web service platform, reports that a total of 37 drugs are set to face patent expirations, paving the way for generic market entry. Consequently, the increasing patent expiration is a significant driver for the pharmaceutical contract development and manufacturing market.

Pharmaceutical contract development and manufacturing companies are actively engaging in acquisitions and forming strategic alliances to strengthen their market presence. This trend reflects a strategic focus on expanding global market reach, meeting client requirements, enhancing production capabilities, and gaining access to cutting-edge technology and new services. The heightened frequency of merger and acquisition activities has led to the consolidation of contract service providers within the industry. For example, in July 2022, Pharma Nobis, a US-based provider of contract manufacturing and private label services, acquired Fagron's U.S. contract manufacturing business. This strategic move allows Pharma Nobis to extend contract manufacturing and private label services to American retailers and consumer healthcare corporations, with Fagron retaining a 20% ownership stake in the company.

Leading companies in the pharmaceutical contract development and manufacturing market are innovating their service portfolios to cater to evolving industry needs. One such offering is the DevPack, a service designed to optimize processes across multiple partners and create a standardized dataset for development process steps. ASM Research Chemicals, a Germany-based company providing contract research and manufacturing services, launched the DevPack service in May 2023. Tailored for active pharmaceutical ingredients (APIs) manufacturing, DevPack streamlines API research, development, and scale-up. It is particularly beneficial for Contract Manufacturing Organizations (CMOs) and pharmaceutical firms aiming for rapid early-stage manufacturing route development, along with supporting analytical development and regulatory submissions.

In August 2022, Catalent, Inc., a US-based provider of delivery technologies, development, and drug manufacturing, completed the acquisition of Metrics Contract Services for $475 million. This strategic move enhances Catalent's capabilities in working with highly potent chemicals and strengthens its expertise in integrated oral solid formulation research, production, and packaging. The acquisition is aimed at assisting clients in streamlining and expediting their processes. Metrics Contract Services is a US-based pharmaceutical contract development and manufacturing organization.

Major companies operating in the pharmaceutical contract development and manufacturing organization (cmo) market report are Lonza Group, Catalent Inc., WuXi AppTec Inc., Pfizer Inc., Recipharm AB, Almac Group, Aenova Group, Baxter International Inc., SGS Life Science Services SA, Jubilant Pharmova Ltd., Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd., IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc., Merck & Co Inc., Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Inc., Johnson & Johnson, Eurofarma Laboratorios S.A., Ache Laboratorios Farmaceuticos S.A., Blanver Farmoquimica e Farmaceutica S.A., Prati-Donaduzzi, Uniao Quimica Farmaceutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd., Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals

North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2023. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical contract development and manufacturing market includes revenues earned by entities by providing drug development and manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical contract development and manufacturing organization (cmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (cmo)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical contract development and manufacturing organization (cmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Contract Manufacturing Services; Contract Research Services
  • 2) By Research Phase: Preclinical; Phase I; Phase II; Phase III; Phase IV
  • 2) By End User: Big Pharmaceutical Companies; Generic Pharmaceutical Companies; Small And Medium-Sized Pharmaceutical Companies
  • Sub segments: Active Pharmaceutical Ingredients (API) Manufacturing; Finished Dosage Formulation (FDF) Development And Manufacturing; Secondary Packaging; Preclinical; Phase I; Phase II; Phase III; Phase IV
  • Companies Mentioned: Lonza Group; Catalent Inc; WuXi AppTec Inc.; Pfizer Inc; Recipharm AB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics

3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trends And Strategies

4. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size and Growth

  • 5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

  • 6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contract Manufacturing Services
  • Contract Research Services
  • 6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • 6.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Big Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Small & Medium-Sized Pharmaceutical Companies

7. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 11.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 14.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 18.1. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 19.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 20.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 21.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 21.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 22.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 23.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 23.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 24.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 24.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 25.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 25.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 26.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 26.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 27.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 28.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 28.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 29.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 29.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape
  • 30.2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Company Profiles
    • 30.2.1. Lonza Group
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Catalent Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. WuXi AppTec Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Pfizer Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Recipharm AB
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Other Major And Innovative Companies

  • 31.1. Almac Group
  • 31.2. Aenova Group
  • 31.3. Baxter International Inc
  • 31.4. SGS Life Science Services SA
  • 31.5. Jubilant Pharmova Ltd
  • 31.6. Dishman Pharmaceuticals
  • 31.7. Kemwell Pvt. Ltd.
  • 31.8. Nipro Corp.
  • 31.9. CMIC Group
  • 31.10. Sawai Pharmaceutical Co., Ltd
  • 31.11. IDT Australia Limited
  • 31.12. Aurigene Pharmaceutical Services Limited
  • 31.13. Vetter Pharma International GMBH
  • 31.14. Consort Medical PLC
  • 31.15. Siegfried Holding AG

32. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Benchmarking

33. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

35. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Future Outlook and Potential Analysis

  • 35.1 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer